Donor cytomegalovirus seropositivity and the risk of leukemic relapse after reduced-intensity transplants

European Journal of Haematology

Volumn 76, Issue 5, 2006, Pages 414-419

  Nachbaur, David ^a,b   Clausen, Johannes ^a   Kircher, Brigitte ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Donor CMV serostatus; Leukemic relapse; Reduced intensity transplant

Indexed keywords

ACICLOVIR; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BUSULFAN; COTRIMOXAZOLE; CYCLOSPORIN A; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY; VALACICLOVIR;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CAUSE OF DEATH; CHI SQUARE TEST; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEATH; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HEALTH CENTER; HUMAN; INCIDENCE; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MYCOSIS; OBSERVATION; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REDUCED INTENSITY CONDITIONING; RISK ASSESSMENT; SEROLOGY; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; VIRUS INFECTION;

ACUTE DISEASE; ADULT; AGED; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTIONS; DISEASE PROGRESSION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33645718032     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00625.x     Document Type: Article

References (23)

1. B oeckh M N ichols WG P apanicolaou G R ubin R W ingars JR Z aia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant 2003 9 543 558.
2. M eyers JD F lournoy N T homas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Inf Dis 1986 153 478 488.
3. B oeckh M N ichols WG. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 2004 103 2003 2008.
4. C wynarsky K R oberts IAG I acobelli S et al. for the Pediatric and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation. Stem cell transplantation for chronic myeloid leukemia. Blood 2003 102 1224 1231.
5. K ollman C H owe CWS A nasetti C et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001 98 2043 2051.
6. L jungman P B rand R E insele H F rassoni F N iederwieser D C ordonnier C. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood 2003 102 4255 4260.
7. N ichols WG C orey L G ooley T D avid C B oeckh M. High risk of death due to bacterial infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Inf Dis 2003 185 273 282.
8. J acobsen N B adsberg JH L önnqvist B R ingdén O V olin L R ajantie J N ikoskelainen J K eiding N for the Nordic Bone Marrow Transplantation Group. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. Bone Marrow Transplant 1990 5 413 418.
9. N achbaur D B onatti H O beraigner W E ibl B K ropshofer G G astl G N ussbaumer W E insele H L archer C. Survival after bone marrow transplantation from cytomeglovirus seropositive sibling donors. Lancet 2001 358 1157 1159.
10. N akamura R B attiwalla M S olomon S F ollman D C hakrabarti S C ortez K H ensel N C hilds R B arrett AJ. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant 2004 10 49 57.
11. M aris M B oeckh M S torer B D awson M W hite K K eng M S andmaier B M aloney D S torb R S torek J. Immunological recovery after haematopoietic cell transplantation with nonmyeloablative conditioning. Exp Hematol 2003 31 941 952.
12. M ohty M G augler B F aucher C et al. Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation. Hematology 2002 7 157 164.
13. M orecki S G elfand Y N agler A O r R N aparstek E V aradi G E ngelhard D A kerstein A S lavin S. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen. Bone Marrow Transplant 2001 28 243 249.
14. G reenberg P C ox C L e B eau MM et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997 89 2079 2088.
15. N achbaur D E ibl B K ropshofer G M eister B M itterschiffthaler A S chennach H F ischer G K opp M G unsilius E G astl G. In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation. J Hematother Stem Cell Res 2002 11 731 737.
16. M c S weeney PA N iederwieser D S hizuru JA et al. Hematopoietic stem ell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001 97 3390 4000.
17. G lucksberg H S torb R F efer A B uckner CD N eiman PE C lift RA L erner KG T homas ED. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974 18 295 301.
18. S hulman HM S ullivan KM W eiden PL M c D onald GB S triker GE S ale GF H ackman R T soi MS S torb R T homas ED. Chronic graft-versus-host syndrome in man. A long term clinicopathologic study of 20 Seattle patients. Am J Med 1980 69 204 211.
19. M arr K S eidel K S lavin M B ownden R S choch H F lowers M C orey L B oeckh M. Prolonged fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study. Blood 2002 96 2055 2061.
20. G aiger A M annhalter C H interberger W H aas O M arosi C K ier P E ichinger S L echner K. Detection of engraftment and mixed chimerism following bone marrow transplantation using a PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor gene. Ann Hematology 1991 63 227 228.
21. L jungman P G riffiths P P aya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Inf Dis 2002 34 1094 1097.
22. K aplan EL M eier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958 53 457 481.
23. G ooley TA L eisenring W C rowley J S torer BE. Estimation of failure probabilities in the presence of competing risks: new representation of old estimators. Stat Med 1999 18 695 706.